Key facts
- This page summarizes Anastasios Gianakakos's Form 4 filing for LianBio (LIANY).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Jan 2022, 15:20.
Anastasios Gianakakos - 29 Dec 2021 Form 4 Insider Report for LianBio (LIANY)
- Reporting relationship
- Director
- Issuer ticker
- LIANY
- Reported as of
- 29 Dec 2021
- Net transaction value
- +$237,197
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2022, 15:20:13 UTC
- Prior SEC filing
- 29 Oct 2021
- Next SEC filing
- 27 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Angela Chen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Anastasios Gianakakos filed Form 4 for LianBio (LIANY) on 03 Jan 2022.
Change
- Previous filing in this sequence was filed on 29 Oct 2021.
- Current net transaction value: +$237,197.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIAN
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $237,197
- Shares
- +36,548
- Change %
- Price
- $6.49
- Shares after
- 36,548
- Date
- 29 Dec 2021
- Ownership
- Direct
LIAN
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 309,623
- Date
- 29 Dec 2021
- Ownership
- By Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LIAN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -36,548
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 109,647
- Date
- 29 Dec 2021
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 36,548
- Exercise price
- $6.49
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
25% of the shares underlying the option vested and became exercisable on the first anniversary of the commencement date, December 17, 2021; the remainder shall vest and become exercisable in 3 equal annual installments such that the option shall be fully vested on December 17, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date.